FDA Adds Boxed Warning to Tofacitinib for Risks of Blood Clots, Death with Higher Dose - Specialty Pharmacy Times

FDA Adds Boxed Warning to Tofacitinib for Risks of Blood Clots, Death with Higher Dose  Specialty Pharmacy Times

Results from an ongoing safety trial of tofacitinib demonstrated an increased risk of blood clots and death associated with a 10-mg twice daily dose of tofacitinib ...



Comments

Popular posts from this blog

Fibromyalgia — Latest Stories — Pain News Network

Chronic Lyme arthritis: A mystery solved?

Epstein-Barr virus and autoimmune diseases